What does ALPHAMEDIS do?

ALPHAMEDIS is a shop in Ans. Public Limited, started on 27 November 1995, 3 establishments.

What is the address of ALPHAMEDIS?

The registered office of ALPHAMEDIS is located at Avenue de l'Energie 8, 4432 Ans.

Is ALPHAMEDIS still active?

Yes. According to the CBE (30 October 2026) ALPHAMEDIS is active, legal situation “Normale toestand”, started on 27 November 1995.

Is ALPHAMEDIS registered on Peppol?

Yes, ALPHAMEDIS is registered on the Peppol network with ID 0208:0456605328.

What is the enterprise number of ALPHAMEDIS?

The enterprise number of ALPHAMEDIS is BE0456605328.

When was ALPHAMEDIS founded?

ALPHAMEDIS was founded on 27 November 1995.

Who are the directors of ALPHAMEDIS?

According to the 2026 annual accounts, the directors of ALPHAMEDIS are: Véronique RIGA, Padraic William DEMPSEY, Owen TIERNAN, Olivier STANGRET.

Is ALPHAMEDIS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 November 1995; 5 annual accounts filed, latest fiscal year 2026; 4 directors known from the annual account; 3 establishments in the CBE.

How much profit did ALPHAMEDIS make in 2026?

ALPHAMEDIS recorded a loss after taxes of € 424,537 in financial year 2026.

What is the revenue of ALPHAMEDIS?

As a small company, ALPHAMEDIS is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 1,337,155.

How much does an employee at ALPHAMEDIS earn?

The average wage cost per full-time employee at ALPHAMEDIS was € 78,900 in 2026: staff costs of € 1.7 million for 21.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does ALPHAMEDIS have?

According to the 2026 annual accounts, ALPHAMEDIS has 21.5 full-time equivalents (FTE).

Does ALPHAMEDIS have a website?

Yes, ALPHAMEDIS has a website at alphamedis.be.

ALPHAMEDIS (Public Limited) - Ans - BE0456605328

Dossier ALPHAMEDIS, printed on 30 October 2026 from databakkes.be/en/0456605328/alphamedis. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2025 and 2026.

Financials

Financial year 2026

ALPHAMEDIS from Ans, company number BE0456605328, closed financial year 2026 with a result of € -424,537 after tax. For that financial year ALPHAMEDIS recorded a gross margin of € 1.3 million and equity of € 951,661. Compared with financial year 2025, the result moved from € -482,638 to € -424,537. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 17, 2026.

What it is worth Healthy

€ 951,661

▼ 31% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -424,537

▲ 12 % less loss than in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 489,398

▼ 4% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 827,661.

People and assets in 2026

Full-time equivalents

21.5

▲ 1.6 vs 2025

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.7 million

▼ 14% vs 2025

€ 78,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 15,916

▲ 71% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 816,913

▲ 52% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 231,497

▼ 3% vs 2025

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2025	2026	Change 2025 → 2026
Gross margin	€ 2,174,736 Gross margin 2022: € 2,174,736 First fiscal year in the series	€ 1,310,012 Gross margin 2023: € 1,310,012 ▼ 40% vs 2022 (€ 2,174,736) Unfavourable step	€ 1,685,937 Gross margin 2025: € 1,685,937 ▲ 29% vs 2023 (€ 1,310,012) Favourable step	€ 1,337,155 Gross margin 2026: € 1,337,155 ▼ 21% vs 2025 (€ 1,685,937) Unfavourable step	▼ 21%
Profit after taxes	€ 72,888 Profit after taxes 2022: € 72,888 First fiscal year in the series	€ -166,193 Profit after taxes 2023: € -166,193 ▼ € 239,080 vs 2022 (€ 72,888) Unfavourable step	€ -482,638 Profit after taxes 2025: € -482,638 ▼ € 316,445 vs 2023 (€ -166,193) Unfavourable step	€ -424,537 Profit after taxes 2026: € -424,537 ▲ € 58,101 vs 2025 (€ -482,638) Favourable step	▲ € 58,101
Equity	€ 2,425,028 Equity 2022: € 2,425,028 First fiscal year in the series	€ 1,858,835 Equity 2023: € 1,858,835 ▼ 23% vs 2022 (€ 2,425,028) Unfavourable step	€ 1,376,198 Equity 2025: € 1,376,198 ▼ 26% vs 2023 (€ 1,858,835) Unfavourable step	€ 951,661 Equity 2026: € 951,661 ▼ 31% vs 2025 (€ 1,376,198) Unfavourable step	▼ 31%
Total debts	€ 711,276 Total debts 2022: € 711,276 First fiscal year in the series	€ 646,098 Total debts 2023: € 646,098 ▼ 9% vs 2022 (€ 711,276) Favourable step	€ 808,916 Total debts 2025: € 808,916 ▲ 25% vs 2023 (€ 646,098) Unfavourable step	€ 1,186,464 Total debts 2026: € 1,186,464 ▲ 47% vs 2025 (€ 808,916) Unfavourable step	▲ 47%
Cash	€ 583,474 Cash 2022: € 583,474 First fiscal year in the series	€ 268,949 Cash 2023: € 268,949 ▼ 54% vs 2022 (€ 583,474) Unfavourable step	€ 508,479 Cash 2025: € 508,479 ▲ 89% vs 2023 (€ 268,949) Favourable step	€ 489,398 Cash 2026: € 489,398 ▼ 4% vs 2025 (€ 508,479) Unfavourable step	▼ 4%
Retained profit	€ 2,301,028 Retained profit 2022: € 2,301,028 First fiscal year in the series	€ 1,734,835 Retained profit 2023: € 1,734,835 ▼ 25% vs 2022 (€ 2,301,028) Unfavourable step	€ 1,252,198 Retained profit 2025: € 1,252,198 ▼ 28% vs 2023 (€ 1,734,835) Unfavourable step	€ 827,661 Retained profit 2026: € 827,661 ▼ 34% vs 2025 (€ 1,252,198) Unfavourable step	▼ 34%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 400,000 Dividend 2023: € 400,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2023 (€ 400,000) Unchanged	€ 0 Dividend 2026: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 3,136,305 Balance sheet total 2022: € 3,136,305 First fiscal year in the series	€ 2,504,934 Balance sheet total 2023: € 2,504,934 ▼ 20% vs 2022 (€ 3,136,305) Unchanged	€ 2,203,917 Balance sheet total 2025: € 2,203,917 ▼ 12% vs 2023 (€ 2,504,934) Unchanged	€ 2,158,272 Balance sheet total 2026: € 2,158,272 ▼ 2% vs 2025 (€ 2,203,917) Unchanged	▼ 2%
Employees (FTE)	20.7 Employees (FTE) 2022: 20.7 First fiscal year in the series	18.8 Employees (FTE) 2023: 18.8 ▼ 1.9 vs 2022 (20.7) Unchanged	19.9 Employees (FTE) 2025: 19.9 ▲ 1.1 vs 2023 (18.8) Unchanged	21.5 Employees (FTE) 2026: 21.5 ▲ 1.6 vs 2025 (19.9) Unchanged	▲ 1.6

Key figures of ALPHAMEDIS, fiscal years 2022 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to ALPHAMEDIS?

What happened at ALPHAMEDIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Padraic William DEMPSEY stepped down as director. NBB
2030 Owen TIERNAN stepped down as director. NBB
2027 Véronique RIGA stepped down as director. NBB
2027 Olivier STANGRET stepped down as director. NBB
Sep 17, 2026 New annual accounts for financial year 2026: loss of € 424,537. Source: NBB ↗
2024 Padraic William DEMPSEY became a director. NBB
2024 Owen TIERNAN became a director. NBB
2021 Véronique RIGA became a director. NBB

In short

From € 72,888 profit in 2022 to € 424,537 loss in 2026.

Paid € 162,148 in corporate taxes since 2022.

Best year ever: 2022, with € 72,888 profit.

On average € 62,200 of value added per employee in 2026.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2026 annual accounts

Véronique RIGA

Director

since 2021 · until 2027

Padraic William DEMPSEY

Director

since 2024 · until 2030

Owen TIERNAN

Director

since 2024 · until 2030

Olivier STANGRET

Director

since 2021 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue de l'Energie 8

4432 Ans

2.233.028.189

Rue des Sablières(BL) 9

7522 Tournai

Active since 1 June 2007

2.316.833.518

Hoogstraat 26

1861 Meise

Active since 1 May 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS alphamedis.be

Technologies

BootstrapContact Form 7Cookie ConsentCookiebotFont AwesomeGoogle AnalyticsGoogle FontsLiteSpeedPHPWPBakeryWPMLWooCommerceWordPressYoast SEOjQueryjQuery UI

Hosting & Email

Email provider

Barracuda

Hosting

OVH, FR

DNS

OVH DNS

Website info

HTTPS Ja

Languages FR, NL

Features

Webshop Jobs Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0456.605.328

VAT number

BE 0456.605.328

Registered office

Avenue de l'Energie 8, 4432 Ans

Names & denominations

ALPHAMEDIS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

27 November 1995

Peppol

Active · Active since 25 Nov 2025

Contact

alphamedis.be

Activities · NACE

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Groothandel in farmaceutische en medische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

ALPHAMEDIS

Warning lights

Financials

What happened to ALPHAMEDIS?

Management

Directors

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions